Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Cash (2016 - 2025)

Bio-Techne has reported Change in Cash over the past 17 years, most recently at $27.9 million for Q4 2025.

  • Quarterly results put Change in Cash at $27.9 million for Q4 2025, up 379.42% from a year ago — trailing twelve months through Dec 2025 was -$4.7 million (down 109.85% YoY), and the annual figure for FY2025 was $10.4 million, up 136.12%.
  • Change in Cash for Q4 2025 was $27.9 million at Bio-Techne, up from -$17.2 million in the prior quarter.
  • Over the last five years, Change in Cash for TECH hit a ceiling of $53.3 million in Q2 2023 and a floor of -$51.0 million in Q1 2022.
  • Median Change in Cash over the past 5 years was $4.6 million (2022), compared with a mean of $367650.0.
  • Biggest five-year swings in Change in Cash: soared 500.31% in 2021 and later tumbled 3122.78% in 2023.
  • Bio-Techne's Change in Cash stood at $15.5 million in 2021, then crashed by 103.7% to -$575000.0 in 2022, then tumbled by 3122.78% to -$18.5 million in 2023, then surged by 46.08% to -$10.0 million in 2024, then soared by 379.42% to $27.9 million in 2025.
  • The last three reported values for Change in Cash were $27.9 million (Q4 2025), -$17.2 million (Q3 2025), and $21.5 million (Q2 2025) per Business Quant data.